Three "Snide" Implications Of The Valeant, Ackman Insider Trading Lawsuit

Judge David Carter says Valeant and Bill Ackman must face an insider trading lawsuit pursuant to their 2014 Allergan takeover bid. The lawsuit could result in a disgorgement of profits from Ackman's Allergan trade. Avoid VRX.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.